Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments.
about
A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion.MicroRNA-21 protects neurons from ischemic deathElectroacupuncture protected pyramidal cells in hippocampal CA1 region of vascular dementia rats by inhibiting the expression of p53 and Noxa.The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke.Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in ratsChanges in gene expression in the rat hippocampus after focal cerebral ischemia.An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.Association Between a Polymorphism (rs2071214) in Baculoviral IAP Repeat Containing 5 Gene (BIRC5) and Ischemic Stroke in Korean Population.Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.Mitochondrial preconditioning: a potential neuroprotective strategy.The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review.Complement in the brain.Inhibition of neuronal ferroptosis protects hemorrhagic brainDoes a redox cycle provide a mechanism for setting the capacity of neuroglobin to protect cells from apoptosis?Developing drug strategies for the neuroprotective treatment of acute ischemic stroke.Electroacupuncture at GV20 and ST36 Exerts Neuroprotective Effects via the EPO-Mediated JAK2/STAT3 Pathway in Cerebral Ischemic Rats.Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties.Erythropoietin: a multimodal neuroprotective agent.Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses.Neuroprotective effect of schizandrin A on oxygen and glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons.Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study.Protective Effects of UCF-101 on Cerebral Ischemia-Reperfusion (CIR) is Depended on the MAPK/p38/ERK Signaling Pathway.Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemiaSC79, the AKT Activator Protects Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury
P2860
Q30838086-814E403B-6123-4220-A6BC-4F841D40B0E9Q33692185-8AB1A0B4-866E-4E74-9D95-E2DB02F82EAAQ33719789-FF3AC535-7CB9-4E77-874A-36A00681D80BQ34681421-D6388868-7BC6-4F12-BB04-B0C911F23AE8Q35132426-1C9F0BDC-7EB4-4191-80DA-3A95940833C5Q35555793-90B525AA-9CF1-44F4-AD88-48124A207B46Q35919831-38FB4792-D0E0-43B9-AF5E-A6EC22EE497AQ36883430-625EC943-F9EB-4DDA-BA11-0EC8BF0D8FBDQ37109952-07E02F46-2FD6-4062-9849-30BBEF146A0AQ37358669-125A497B-5E08-4435-910C-FDB5E038132AQ37788545-F94716ED-8D78-43AD-AF63-DA85D20E5253Q37820180-F044BC08-CBFC-4EEB-BE15-65BD6F5A4074Q37872442-DCA6059E-F110-4BEB-AD7E-477D7C12031FQ38730939-EA73A239-AD7D-4D4E-A021-CF45909A765EQ39390960-5993C91F-EB43-4B0A-B785-8416A9D8B7BCQ40429078-22A8721A-842B-4D1B-B60A-6D94D4AB6D30Q41467848-B7B1E53E-1761-4FC7-A311-45772358215FQ42786900-7FD2D5EB-696E-42C5-9818-3FAFAB8E30ADQ42922791-57E56729-5EB7-4356-A628-4C464B51C4F2Q47567450-A7244346-E3D8-41E1-B2F2-5D3F67B59CF7Q47627887-F6A8CAB1-28A8-4C7A-B08A-655B95B2165FQ51749703-B38B1988-6832-4A40-A2B5-5C657AED5A1BQ52148569-03237DBD-47BF-452E-A894-78C55E0ADE80Q57292417-A0BF0834-3466-48F2-B5CF-CF8578749D54Q58801492-092EAA33-6F80-43AC-A904-E14669E59E86
P2860
Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Apoptosis dominant in the peri ...... t of antiapoptotic treatments.
@en
Apoptosis dominant in the peri ...... t of antiapoptotic treatments.
@nl
type
label
Apoptosis dominant in the peri ...... t of antiapoptotic treatments.
@en
Apoptosis dominant in the peri ...... t of antiapoptotic treatments.
@nl
prefLabel
Apoptosis dominant in the peri ...... t of antiapoptotic treatments.
@en
Apoptosis dominant in the peri ...... t of antiapoptotic treatments.
@nl
P2093
P2860
P356
P1433
P1476
Apoptosis dominant in the peri ...... et of antiapoptotic treatments
@en
P2093
Anders Paetau
Marja-Liisa Karjalainen-Lindsberg
Tiina Sairanen
P2860
P304
P356
10.1093/BRAIN/AWH645
P407
P577
2005-11-04T00:00:00Z